Report - Sorafenib for renal cell carcinoma E OS TUMORES DO... · Sorafenib (Nexavar®) A Novel, Orally-Active Multi-Kinase Inhibitor Approved in the US in Dec 2005 for advanced RCC In vitro

Please pass captcha verification before submit form